This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Analysts Estimate Trupanion (TRUP) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Trupanion (TRUP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Trupanion (TRUP) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Trupanion (TRUP) delivered earnings and revenue surprises of 500.00% and 2.72%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Here's Why You Should Retain Brown & Brown in Your Portfolio
by Zacks Equity Research
Brown & Brown (BRO) is poised to benefit from constant top-line growth and solid cash flow generating abilities.
Dull Near-Term Prospects for Accident & Health Insurance
by Tanuka De
Accident and Health Insurance industry should see new sales getting affected while frequency of claims from essential service industries are bound to rise.
Why Trupanion (TRUP) Might Surprise This Earnings Season
by Zacks Equity Research
Trupanion (TRUP) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season
Zacks.com featured highlights include: MagnaChip Semiconductor, International Money Express, USANA Health Sciences and Trupanion
by Zacks Equity Research
Zacks.com featured highlights include: MagnaChip Semiconductor, International Money Express, USANA Health Sciences and Trupanion
4 Top-Ranked Liquid Bets to Build a Successful Portfolio
by Zacks Equity Research
Here are four excellent liquid stocks that can contribute to making an outstanding portfolio for yield-seeking investors.
Trupanion (TRUP) Q4 Earnings Preview: What's in the Cards?
by Zacks Equity Research
Trupanion (TRUP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Unum (UNM) Rides on Premium Growth, Firm Financial Standing
by Zacks Equity Research
Unum (UNM) gains traction from strong contributions of its U.S. and International segments, investment in technology and solid liquidity.
The Zacks Analyst Blog Highlights: RenaissanceRe, MGIC Investment, Hallmark Financial Services and Trupanion
by Zacks Equity Research
The Zacks Analyst Blog Highlights: RenaissanceRe, MGIC Investment, Hallmark Financial Services and Trupanion
4 Insurance Stocks for Your Investment Portfolio in 2020
by Zacks Equity Research
Rising insurance premium rates, solid capital position, changes to product portfolio and stable interest rate should drive insurance stocks in 2020.
Moving Average Crossover Alert: Trupanion
by Zacks Equity Research
Trupanion, Inc. (TRUP) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
MetLife to Foray Into Pet Insurance Via PetFirst Acquisition
by Zacks Equity Research
MetLife (MET) to acquire PetFirst to enter the rapidly growing pet insurance market.
Will Trupanion Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor Trupanion.
Aflac Acquires Argus, Expands U.S. Segment Product Suite
by Zacks Equity Research
Aflac's (AFL) acquisition of Argus equips it to provide Dental and Vision products to customers in the United States.
Trupanion (TRUP) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Trupanion (TRUP) delivered earnings and revenue surprises of 200.00% and 1.92%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Trupanion (TRUP) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Trupanion (TRUP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Trupanion (TRUP) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Trupanion (TRUP) delivered earnings and revenue surprises of -100.00% and 1.00%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Trupanion (TRUP) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Trupanion (TRUP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Trupanion (TRUP) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Trupanion (TRUP) delivered earnings and revenue surprises of -300.00% and 1.23%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Trupanion (TRUP) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Trupanion (TRUP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Accident and Health Insurance Near-Term Prospects Bright
by Tanuka De
Increased underwriting exposure, sustained decrease in claims frequency rates, and conservative reserve levels should drive Accident and Health Insurance industry's performance.
Trupanion (TRUP) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Trupanion (TRUP) delivered earnings and revenue surprises of -200.00% and 0.83%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Zacks.com featured highlights include: Crocs, Commvault, Fabrinet, Trupanion and WNS
by Zacks Equity Research
Zacks.com featured highlights include: Crocs, Commvault, Fabrinet, Trupanion and WNS
5 Top-Notch Liquid Stocks to Reap High Portfolio Returns
by Zacks Equity Research
Here are five impressive liquid stocks that are poised to offer marvelous returns.